-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Asterias Biotherapeutics, Inc. (AST) on Behalf of Stockholders and Encourages AST Investors to Contact the Firm
-
-
-
-
-
-
-
Asterias Biotherapeutics Reports First Quarter Financial Results and Recent Development Progress
-
-
-
-
-
-
-
Asterias Biotherapeutics (AST) Names Michael Mulroy as President & CEO; Steve Cartt to Step Down
-
-
-
-
-
-
-
Asterias Biotherapeutics (AST) Names New CEO
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 6/15: (NKA) (TRAK) (ORPN) Higher; (ERN) (AMCN) (AST) Lower
-
-
-
1,155,357 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

